June 20, 2018 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, has made a first on-site installation of a prototype version of INIFY(TM) Prostate, a sophisticated AI-based decision support tool, with the potential to facilitate and significantly speed up prostate cancer diagnosis based on digitalized H&E stained biopsy samples. The installation was made through the fully integration with the Hospital's Laboratory Information System at the pathology department at Ospedale Cannizzaro in Catania, Italy.
Stockholm, June 14, 2018 The ContextVision AB:s Profit Sharing Foundation has sold and purchased shares in ContextVision AB in accordance with the rules related to the foundation. The ContextVision AB:s Profit Sharing Foundation has sold 11,400 shares during the period May 5 – May 29, at an average price of 52,95 NOK/share, in […]
May 28, 2018, - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is making their first appearance in the field of digital pathology at ECDP/NDP, the 14th European Congress on Digital Pathology and the 5th Nordic Symposium on Digital Pathology, May 29 to June 1. Here, they will be introducing their upcoming product INIFY(TM) Prostate, a new decision support tool based on artificial intelligence and deep learning.
May 18th, 2018 - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, and its academic partners at Uppsala University and Uppsala Hospital have been awarded a grant from Sweden's innovation agency, Vinnova, for a continuation of a research program within digital pathology research. The company has already achieved very encouraging results in preliminary studies. The grant will cover costs at the hospital and at Uppsala University.
ContextVision reaches another top position in a prestigious competition using deep learning in digital pathology
May 17, 2018, - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, placed second in a renowned international competition on automated image analysis called the Camelyon Challenge.
On the 9th of May 2018, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The annual financial report regarding 2017 was presented, and approved by the AGM. Disposition of financial results according to the proposal of the Board of Directors was approved. The Managing Director and the Board of Directors were discharged […]
STOCKHOLM – April 26, 2018 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, released its report for Q1 2018, the strongest opening quarter in its history. Q1 sales passed 19 MSEK for the first time (19,2 MSEK), up 11 percent compared to first quarter last year. “We are very proud […]
Stockholm, April 5(th), 2018 – ContextVision hereby invites shareholders to the Annual General Meeting on May 9, 2018. Please find attached the invitation including agenda and details on how to register. Please contact: email@example.com for any questions regarding the AGM. Download pdf »
Stockholm, April 5(th), 2018, Please find ContextVision’s Annual Report 2017 attached. The report can also be found on the company’s website: www.contextvision.se For inquiries, please contact CFO Ann-Charlotte Linderoth E-mail: firstname.lastname@example.org Download pdf »
On March 16th 2018, ContextVision held a company presentation in Oslo. The arrangement was held at Norne Securities AS premises at Roald Amundsens gt. 6, Oslo. CEO Anita Tollstadius gave an update of the company’s development and shared the company’s future direction. Arto Järvinen, Director of R&D, and Ann-Charlotte Linderoth, CFO, were also attending the presentation. […]